A look at the Industry Canada web site will tell you that Canadian pharmaceutical sales represent 2.6% of the global market, the 8th largest market globally, and the fastest growing. Admittedly, these current statistics on the site are probably at least one year behind actual fact. Hiring within the manufacturing part of the industry itself rose from 23,714 in 2001 to 27,016 in 2012. Also, as expected, the greater majority of companies are located in ON or QC.
What are they manufacturing? 60% of prescriptions purchased in Canada are generic in nature, but generics in general represent one quarter of all sales.
Who are the leaders? Johnson and Johnson, Astra-Zeneca, Pfizer,Teva, Apotex, Merck, Novartis, GSK, Abbott, and Roche. One of the most inclusive lists of all companies is published by Contact Canada, which boasts many different publications in related industries, but one specifically focusing on drug development and outsourcing – listings are free, and carry information on Company profiles, key contacts, tel, fax, websites, emails, corporate data, and product andervice areas.
The Canadian Generic Pharmaceutical Association (CGPA) represents 9 manufacturers and distributors of finished generic pharmaceutical products and 1 distributor of active pharmaceutical chemicals. Canada has about 200 CMOs and CROs operating in the pharma space.
In 2012, Canada’s spending on drugs in terms of health expenditure exceeded 33 billion dollars. The foremost therapeutic categories are cardiovascular, neuro-therapies (anti-arthritics) and GI.